Skip to main content
Premium Trial:

Request an Annual Quote

UPDATED: DoubleTwist Offers Upgraded Database

This story has been updated from a previous version.

NEW YORK, Feb 8 – Bioinformatics tool provider DoubleTwist on Thursday said it added new features to its Prophecy toolkit, which includes the company's annotated human genome database and associated software.

Prophecy now includes Prophecy Genes, a set of human genes the company located using a proprietary algorithm. The Oakland, Calif.-based company said the annotated human genome database now includes more than 3 billion human DNA base pairs.

" We actually do minor updates every two weeks, but this is a major update," a company spokeswoman said.

The database can be accessed through or licensed through DoubleTwist's Prophecy database and toolkit.

DoubleTwist said its offerings now incorporated improved gene prediction methodologies and expanded gene representation capabilities. The database has about 500,000 SNPs and 100,000 sequence tag sites mapped to more than 32,000 bacterial artificial chromosomes, organized into contigs.

The company has about 25-30 customers for its products, plus " thousands and thousands" of users for its website, the spokeswoman said. Doubletwist will make the updates to Propecy available to its current users.

The company, which announced plans to go public last September, is currently waiting for market conditions to improve before attempting the offering.

" We're in a holding pattern," the spokeswoman said. 

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.